Report7 sources · 2 verifiedHigh
CDSCO Approves India's First Dengue Vaccine
The Drugs Controller General of India has granted market authorisation for Takeda Biopharmaceuticals' QDENGA for individuals aged four to 60, regardless of prior infection or screening requirements.
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved QDENGA, the country's first dengue vaccine, manufactured by Takeda Biopharmaceuticals. The clearance marks a significant addition to national prevention efforts against the mosquito-borne disease.